Antineoplastics/bevacizumabLack of efficacy: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1913卷 / 1期

关键词：

D O I：

10.1007/s40278-022-18223-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：73 / 73

相关论文

共 50 条

[1] BevacizumabLack of efficacy : 2 case reports
[J]. Reactions Weekly, 2023, 1953 (1) : 109 - 109
[2] Antineoplastics/epirubicinLack of efficacy: 3 case reports
[J]. Reactions Weekly, 2022, 1927 (1) : 78 - 78
[3] BevacizumabLack of efficacy and small cerebral haemorrhage: 3 case reports
[J]. Reactions Weekly, 2023, 1985 (1) : 115 - 115
[4] Antineoplastics and methylprednisoloneLack of efficacy: 3 case reports
[J]. Reactions Weekly, 2023, 1938 (1) : 181 - 181
[5] Antineoplastics/nivolumab/osimertinibLack of efficacy: 3 case reports
[J]. Reactions Weekly, 2022, 1922 (1) : 88 - 88
[6] Antineoplastics/folinic-acidLack of efficacy: 3 case reports
[J]. Reactions Weekly, 2023, 1959 (1) : 94 - 94
[7] Antineoplastics/folinic acid/hydroxychloroquineLack of efficacy: 3 case reports
[J]. Reactions Weekly, 2023, 1963 (1) : 83 - 83
[8] Antineoplastics/immunotherapiesLack of efficacy and GI toxicity: 3 case reports
[J]. Reactions Weekly, 2022, 1927 (1) : 83 - 83
[9] Antineoplastics/epirubicinLack of efficacy and Pneumocystis pneumonia: 3 case reports
[J]. Reactions Weekly, 2022, 1900 (1) : 59 - 59
[10] Antineoplastics/immunosuppressantsLack of efficacy: 4 case reports
[J]. Reactions Weekly, 2022, 1928 (1) : 60 - 60

← 1 2 3 4 5 →